ReviewBiodesign research2025
A comprehensive review on violacein production by microbial fermentation.
Review in Biodesign research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Programmable in vivo mRNA circularization for enhanced gene expression in bacteria.Nucleic acids research · 2026Article
- Biosynthesis and Microbial Production of Carminic Acid: From Pathway Elucidation to Synthetic Biology.Microorganisms · 2026Review
- Discovery of Virulence Attenuator of Chromobacterium violaceum CV026 From Marine-Derived Fungus Aspergillus ochraceus LSD-13 by Inhibiting Quorum Sensing and Destroying Biofilm.Chemistry & biodiversity · 2026Article
- Waste to wealth: circular approaches for microbial pigment production.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Violacein is a natural purple secondary metabolite with a wide range of biological activities including antibacterial, anticancer, antioxidant, and antiparasitic properties, rendering it a highly promising candidate for applications in medicine, agriculture, and food industries. Despite its availability from natural sources, a profound understanding of its production mechanisms has long been lacking. High-level production of violacein has been achieved through integrated strategies, including heterologous expression of its biosynthetic pathway in recombinant strains, enhancement of tryptophan precursor supply, and optimization of fermentation conditions. These approaches offer a flexible and scalable platform for violacein biosynthesis. Furthermore, recent efforts have focused on utilizing agro-industrial waste as a cost-effective and sustainable feedstock to further improve production efficiency and environmental compatibility. This review provides a comprehensive overview of the latest advancements in violacein production, examines the challenges associated with its application, and proposes strategies for optimizing gene expression, refining fermentation protocols, and utilizing low-cost raw materials to facilitate the efficient and sustainable violacein production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.